We haveenough cashto go wellinto 2023I/ONTAKis our leadassetThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Myron Holubiakand I founded aprivatecompany in2013I'm ashareholdermyselfHemorrhoidsis a $2BmarketThere are noFDAapproveddrugs to treathemorrhoidsAn actualiMSCupdateWe had aphase 2btrial with100%efficacyWe expect tofinish theMino-Loktrial this yearNot manycompaniesthis size with2 late stageassetsOnly biotechwith 2 Myron'son theleadershipteamOur Halo-Lido trial willhave finalpatient byend of 2022Insidersinvested$26.5mI won't diluteshareholdersWe intendto submita BLA in2H 2022We willhaveexclusivityI/ONTAKwas thebest deal Iever madeMino-Lokis our leadassetI/ONTAK'spotentialmarket is>$300mWe will openupinternationalsites forMino-Lok trialMino-WrapMino-Lokpotentialmarket>$1BWe haveenough cashto go wellinto 2023I/ONTAKis our leadassetThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Myron Holubiakand I founded aprivatecompany in2013I'm ashareholdermyselfHemorrhoidsis a $2BmarketThere are noFDAapproveddrugs to treathemorrhoidsAn actualiMSCupdateWe had aphase 2btrial with100%efficacyWe expect tofinish theMino-Loktrial this yearNot manycompaniesthis size with2 late stageassetsOnly biotechwith 2 Myron'son theleadershipteamOur Halo-Lido trial willhave finalpatient byend of 2022Insidersinvested$26.5mI won't diluteshareholdersWe intendto submita BLA in2H 2022We willhaveexclusivityI/ONTAKwas thebest deal Iever madeMino-Lokis our leadassetI/ONTAK'spotentialmarket is>$300mWe will openupinternationalsites forMino-Lok trialMino-WrapMino-Lokpotentialmarket>$1B

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. We have enough cash to go well into 2023
  2. I/ONTAK is our lead asset
  3. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  4. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  5. Myron Holubiak and I founded a private company in 2013
  6. I'm a shareholder myself
  7. Hemorrhoids is a $2B market
  8. There are no FDA approved drugs to treat hemorrhoids
  9. An actual iMSC update
  10. We had a phase 2b trial with 100% efficacy
  11. We expect to finish the Mino-Lok trial this year
  12. Not many companies this size with 2 late stage assets
  13. Only biotech with 2 Myron's on the leadership team
  14. Our Halo-Lido trial will have final patient by end of 2022
  15. Insiders invested $26.5m
  16. I won't dilute shareholders
  17. We intend to submit a BLA in 2H 2022
  18. We will have exclusivity
  19. I/ONTAK was the best deal I ever made
  20. Mino-Lok is our lead asset
  21. I/ONTAK's potential market is >$300m
  22. We will open up international sites for Mino-Lok trial
  23. Mino-Wrap
  24. Mino-Lok potential market >$1B